AMD Crosses $1 Trillion Market Cap as Wall Street Rewrites Its Models

3 min read
AMD Crosses $1 Trillion Market Cap as Wall Street Rewrites Its Models
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

AMD's stock has pushed past a $1.018 trillion market cap at $623.77 a share, and sell-side analysts are rewriting their models to keep up. Upward EPS revisions, gigawatt-scale AI deals, and a looming Q3 report now decide whether the valuation holds.

AMD has entered a new phase of sell-side coverage after its stock crossed a $1.018 trillion market cap at $623.77. The chipmaker builds the CPUs, GPUs, and rack-scale AI systems that hyperscalers now require as a second source alongside Nvidia. The stock has climbed from a $222.50 filing price in early 2026 to today's level on gigawatt-scale AI deals with OpenAI, Meta, Anthropic, Microsoft Azure, and Oracle Cloud.

Analysts Race to Raise Targets

Piper Sandler initiated coverage with an Overweight rating and a $600 target. Raymond James upgraded the stock to Strong Buy at $641. Bank of America lifted its target to $620, citing Helios rack production and a revised $2 trillion AI infrastructure market. Management expects the data center AI accelerator market to grow more than 45% annually to roughly $1.4 trillion by 2030.

AMD trades at a forward P/E of 36 with a PEG of 0.57. Its 2027 consensus EPS has moved from $13.10 ninety days ago to $15.57, following 33 upward revisions in the past 30 days against just 3 downward. Q2 revenue reached $11.54 billion, up 50.11% year over year, with Data Center revenue of $6.718 billion, up 107%.

Where Bears See a Blow-Off Top

However, AMD's trailing P/E of 235 and free cash flow yield of 0.66% leave no room for error. Capex nearly tripled year over year in Q2, pushing free cash flow down 9.89%, while gaming revenue fell 31% year over year and U.S. export controls on the MI308 remain an overhang. AMD is up 290.37% over the past year and sits fractionally above its 52-week high of $624.52, and bears argue that Helios yields, HBM supply, and 2027 deployment timing are execution variables the valuation already treats as solved.

Q3 Results Will Test the Model

Q3 guidance calls for roughly $13 billion in revenue, about 41% growth, and management said initial Helios shipments begin this quarter. AMD trades against an average analyst target of $616.51, implying roughly 1% downside on consensus. Still, 54 analysts cover the stock with 4 Strong Buy, 39 Buy, 11 Hold, and zero Sell ratings. The stock has returned 191.26% year to date versus 13.42% for the S&P 500.

MI450 volumes are set to ramp into Q4, and the first gigawatt of the Anthropic deployment is expected to land in the first half of 2027. The thesis breaks if Helios yields disappoint, HBM allocation tightens, or Nvidia responds competitively — both Q3 results against the $13 billion guide and 2027 EPS revision direction currently point up.

Source: 24/7 Wall St.

Trading involves risk.

Most traded markets

XAU / USD
-1.79% 4,280.33
BRENT
+3.24% 102.344
BTC / USD
-2.21% 84,102.5
EUR / USD
-0.55% 1.13857
USTEC
-1.07% 30,375.67
META
+0.47% 743.71
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Stock News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.